S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Ritter PharmaceuticalsIntelliPharmaCeutics IntlInternational Stem CellMOTIF BIO PLC/SInnovus Pharmaceuticals
SymbolNASDAQ:RTTROTCMKTS:IPCIFOTCMKTS:ISCONASDAQ:MTFBN/A
Price Information
Current Price$0.29$0.10$0.49$0.19N/A
52 Week RangeHoldBuyN/ABuyN/A
Analyst Ratings
Consensus RecommendationHoldBuyN/ABuyN/A
Consensus Price TargetN/A$6.00N/A$5.00N/A
% Upside from Price TargetN/A5,680.35% upsideN/A2,531.58% upsideN/A
Trade Information
Market Cap$2.76 million$2.29 million$3.39 million$3.04 million$3.78 million
Beta1.151.440.78-0.012.89
Average Volume597,624115,8935,209331,44617,924
Sales & Book Value
Annual RevenueN/A$1.71 million$11.09 millionN/A$23.99 million
Price / SalesN/A1.340.33N/A0.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.22 per share($0.11) per share$0.37 per share($0.60) per share$0.05 per share
Price / BookN/A-0.941.32N/A0.00
Profitability
Net Income$-16,870,000.00$-13,750,000.00N/A$-13,980,000.00$-8,280,000.00
EPS($3.66)N/A($0.33)($0.07)($4.16)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/A0.00
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-289.69%-15.97%N/A-34.51%
Return on Equity (ROE)-1,214.08%-2,640.60%-87.16%N/A-682.54%
Return on Assets (ROA)-176.15%-146.55%-18.86%N/A-78.57%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.32%N/AN/A
Current Ratio1.70%0.27%0.75%0.26%0.68%
Quick Ratio1.70%0.43%0.45%N/A0.36%
Ownership Information
Institutional Ownership Percentage6.58%0.14%N/A9.58%10.38%
Insider Ownership Percentage15.40%N/A83.16%N/A16.43%
Miscellaneous
Employees7N/A42712
Shares Outstanding9.43 million22.09 million7.53 million14.83 million2.36 million
Next Earnings Date11/8/2019 (Estimated)10/21/2019 (Estimated)11/21/2019 (Estimated)N/AN/A
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
 Ritter PharmaceuticalsIntelliPharmaCeutics IntlInternational Stem CellMOTIF BIO PLC/SInnovus Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel